Caseware UK (AP4) 2023.0.135 2023.0.135 2024-12-312024-12-312025-05-212falsetrue2024-01-012falsefalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13145253 2024-01-01 2024-12-31 13145253 2023-01-01 2023-12-31 13145253 2024-12-31 13145253 2023-12-31 13145253 c:Director1 2024-01-01 2024-12-31 13145253 c:Director2 2024-01-01 2024-12-31 13145253 d:CurrentFinancialInstruments 2024-12-31 13145253 d:CurrentFinancialInstruments 2023-12-31 13145253 d:Non-currentFinancialInstruments 2024-12-31 13145253 d:Non-currentFinancialInstruments 2023-12-31 13145253 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 13145253 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 13145253 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 13145253 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 13145253 d:ShareCapital 2024-12-31 13145253 d:ShareCapital 2023-12-31 13145253 d:SharePremium 2024-12-31 13145253 d:SharePremium 2023-12-31 13145253 d:RetainedEarningsAccumulatedLosses 2024-12-31 13145253 d:RetainedEarningsAccumulatedLosses 2023-12-31 13145253 c:FRS102 2024-01-01 2024-12-31 13145253 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 13145253 c:FullAccounts 2024-01-01 2024-12-31 13145253 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 13145253 6 2024-01-01 2024-12-31 13145253 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 13145253










ERGENIX LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
ERGENIX LIMITED
REGISTERED NUMBER: 13145253

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 4 
804,002
804,002

  
804,002
804,002

Current assets
  

Debtors: amounts falling due within one year
 5 
3,245
5,460

  
3,245
5,460

Creditors: amounts falling due within one year
 6 
(3,271)
(5,452)

Net current (liabilities)/assets
  
 
 
(26)
 
 
8

Total assets less current liabilities
  
803,976
804,010

Creditors: amounts falling due after more than one year
 7 
(404,000)
(404,000)

  

Net assets
  
399,976
400,010


Capital and reserves
  

Called up share capital 
  
50
50

Share premium account
  
399,900
399,900

Profit and loss account
  
26
60

  
399,976
400,010


Page 1

 
ERGENIX LIMITED
REGISTERED NUMBER: 13145253
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Mr Gagan Kumar Jairath
Mr Zaheer Mohammed
Director
Director


Date: 21 May 2025

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
ERGENIX LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Ergenix Limited is a private company, limited by share capital, incorporated in England and Wales under registration number 13145253. The address of the registered office of the company is situated at 16 - 20 St Augustines Gate, Hedon, Hull, East Ridings of Yorkshire, HU12 8EX.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in the Income statement for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

 
2.3

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).

Page 3

 
ERGENIX LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

4.


Fixed asset investments





Unlisted investments

£



Cost or valuation


At 1 January 2024
804,002



At 31 December 2024
804,002




The company owns 100% issued share capital of Caring Nationwide Limited and Faith Pharma Limited.


5.


Debtors

2024
2023
£
£


Amounts owed by subsidiary company
3,245
5,460

3,245
5,460



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Directors' loan account
52
52

Accruals and deferred income
3,219
5,400

3,271
5,452



7.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Amounts owed to subsidiary company
404,000
404,000

404,000
404,000


Page 4

 
ERGENIX LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

8.


Controlling party

There is no controlling party.

 
Page 5